Drugs.com Company Profile
Drugs.com is the leading online drug information resource with over seven million unique visitors per month (ComScore, June 2012). Providing free, independent, peer-reviewed, and up-to-date information at both consumer and professional levels, Drugs.com empowers patients and caregivers to take charge of their health and be more informed than ever before. The site includes many interactive tools and mobile apps to assist consumers, healthcare professionals and researchers, such as personal medication records, a drug interaction checker, pill identification wizard, symptom checker, pharma sales statistics and more.
News from Drugs.com:
Drugs.com Releases Q2 Sales for Top 100 U.S. Prescription Drugs: Humira Climbs into Top 5 and Posts Double-Digit Growth
NEW YORK, Aug. 14, 2013 /PRNewswire/ — Drugs.com, the leading online clinical drug resource, today released second quarter 2013 U.S. prescription sales data for the top 100 drugs. Since Q2 2012, Otuska's antipsychotic Abilify and AstraZeneca's acid reducer Nexium have held either the number one or two spot in top dollar sales. This quarter, both agents […]
Drugs.com Releases Q1 Sales for Top 100 U.S. Drugs: Rough U.S Flu Season Boosts Numbers for Tamiflu
NEW YORK, May 6, 2013 /PRNewswire/ — Drugs.com, the leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs. (Photo: http://photos.prnewswire.com/prnh/20130506/PH07894-a ) (Photo: http://photos.prnewswire.com/prnh/20130506/PH07894-b ) The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka's second generation antipsychotic, […]
Drugs.com Launches iOS and Android Mobile App to Empower Patients and Providers Alike
Clean lines and an instinctive user interface frames a practical prescription management tool for consumers on-the-go NEW YORK, March 8, 2013 /PRNewswire/ — Drugs.com, the leading online clinical drug resource, today announced they have launched the Drugs.com Medication Guide, a mobile app to facilitate patient engagement in their own medication management. The "Drugs.com Medication Guide" […]
Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
Abilify Overtakes Nexium as the Top Drug by Sales NEW YORK, Feb. 13, 2013 /PRNewswire/ — Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs. At the close of 2012, Otsuka's antipsychotic Abilify overtakes AstraZeneca's acid reducer Nexium and moves into the number one […]
Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
Drugs.com, the leading online clinical drug resource, today released third quarter 2012 U.S. prescription sales data for the top 100 drugs NEW YORK, Nov. 21, 2012 /PRNewswire/ — As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck's asthma and allergy preventive Singulair predictably drops out of the top […]
Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
NEW YORK, Aug. 21, 2012 — Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top-selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands […]
Top 100 Drug Sales Data Released – Plavix Leads the Way
Drugs.com Stats Center Lists the Top 100 U.S. Drugs in Q1 2012 NEW YORK, July 18, 2012 — Drugs.com, the leading online clinical drug resource, today released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood-thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers. Top Five Drugs […]
